UPDATE : Wednesday, January 17, 2018
Celltrion launches anti-blood cancer biosimilar in Germany
Celltrion셀트리온 Inc. has launched its biosimilar to treat hematologic maligna...
by Constance Williams  |  2017-05-18 17:00
Hanmi wins approval for 1st asthma-rhinitis combination drug
Hanmi Pharmaceutical said Wednesday that the company recently won the appro...
by Constance Williams  |  2017-05-17 17:32
Young children of pharmaceutical firms’ owners have shares
Most pharmaceutical companies in Korea are run by owners’ families with the...
by Nam Doo-hyun  |  2017-05-17 17:18
Ildong Pharmaceutical develops its first new drug
The Ministry of Food and Drug Safety (MFDS) has approved Besivo Tab. (compo...
by Lee Hye-seon  |  2017-05-17 14:42
Sanofi, LG Chemical in court battle over Zemiglo
The legal battle between Sanofi-Aventis and LG Chemical over the copyright ...
by Lee Hye-seon  |  2017-05-16 16:41
P2 trial over for GemVax’s prostate disease drug
GemVax & KAEL (CEO: Kim Sang-Jae김상재) completed its phase two clinical trial...
by Marian Chu  |  2017-05-15 11:00
‘Korean pharmaceuticals should expand US export with new drugs’
With the United States stepping up protectionist measures, a state agency h...
by Nam Doo-hyun  |  2017-05-11 17:18
Roche’s bladder cancer drug fails P3 trial
Roche’s Tecentriq (compound: atezolizumab), the first immunotherapeutic bla...
by Constance Williams  |  2017-05-11 16:25
Celltrion adds reason why Remsima can target US market
Celltrion has secured additional grounds for its biosimilar Remsima, called...
by Constance Williams  |  2017-05-11 11:50
Investors focus on Moon-related shares
The news of Moon Jae-in’s election victory is jolting the stock market, too...
by Nam Doo-hyun  |  2017-05-10 20:02
FDA gives accelerated approval to bladder cancer drug
The U.S. Food and Drug Administration granted accelerated approval Tuesday ...
by Constance Williams  |  2017-05-10 11:11
Korea’s share remains small in multinational pharmaceuticals’ operation
What is the proportion of the Korean market among multinational pharmaceuti...
by Marian Chu and Nam Doo-hyun  |  2017-05-09 02:53
Can Jardiance threaten Forxiga's dominance in treating diabetes?
Korean regulators have officially recognized the effect of SGLT-2 (sodiumgl...
by Park Gi-taek  |  2017-05-04 13:30
‘Korean drug market to grow twice faster than GDP until 2021’
Korea’s pharmaceutical market is likely to grow 4.4 percent on annual avera...
by Lee Hye-seon  |  2017-05-02 14:33
FDA okays first drug for Batten disease
Biomarin Pharmaceutical won the go-ahead from the U.S. Food and Drug Admini...
by Constance Williams  |  2017-04-28 15:49
JW Pharmaceutical worst of 10 major drugmakers for women to work in
In every election, presidential candidates have promised to shatter glass c...
by Nam Doo-hyun  |  2017-04-28 12:07
FDA approves 1st treatment for liver cancer in decade
The U.S. Food and Drug Administration Thursday expanded the approved use of...
by Constance Williams  |  2017-04-28 11:25
Boryung’s 1Q sales hit ₩99.8 billion
Boryung Pharmaceuticals보령제약 recorded sales of 99.8 billion won ($88.3 milli...
by Lee Hye-seon  |  2017-04-27 14:59
How Daewoong released Korea’s 1st generic drug in US?
All eyes of Korean drugmakers are on Daewoong Pharmaceutical, as it has ach...
by Lee Hye-seon  |  2017-04-27 13:28
Expectations rise about new bio drug going global
AFSTYLA, a hemophilia therapy developed by SK Chemicals SK케미칼이 jointly with...
by Lee Hye-seon  |  2017-04-26 18:06
Back to Top